JK
Jay Kumar
About Jay Kumar
Data last updated:
Jay Kumar is a Director at Biosam Life Science Private Limited (since 2021) and Director at Rajtilak Pharmaceuticals Private Limited (since 2026). The companies operate in Non-Profit Organizations. The largest current company by reported revenue is Biosam Life Science Private Limited at ₹1.14 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Dec 2021 | 2021 | ₹1.14 Cr (FY 2025) | Active | |
| Director | 14 Jul 2026 | 2026 | Active |
Board colleagues of Jay Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Tilak Kumar | 09446617 | Biosam Life Science Private Limited | Director |
| Shailendra Kumar Singh | 11823597 | Rajtilak Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jay Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jay Kumar
Jay Kumar currently holds 2 directorships: Biosam Life Science Private Limited (Director, since 23 Dec 2021, revenue ₹1.14 Cr (FY 2025)); Rajtilak Pharmaceuticals Private Limited (Director, since 14 Jul 2026).
Jay Kumar was first appointed on 23 Dec 2021 as Director at Biosam Life Science Private Limited. The most recent appointment on record is 14 Jul 2026 at Rajtilak Pharmaceuticals Private Limited.
The current boards of Jay Kumar's companies include Tilak Kumar (Biosam Life Science Private Limited), Shailendra Kumar Singh (Rajtilak Pharmaceuticals Private Limited).